Cargando…
Can adjuvant radiotherapy be omitted for oral cavity cancer patients who received neoadjuvant therapy and surgery? A retrospective cohort study
Surgery and postoperative adjuvant therapy comprise the standard treatment for locally advanced resectable oral squamous cell carcinoma (LAROSCC), while preoperative neoadjuvant therapy is being explored without sufficient confirmation of improved survival. De-escalation regimens after neoadjuvant t...
Autores principales: | Ju, Wutong, Zhang, Yiyi, Liu, Ying, Sun, Jingjing, Li, Jiang, Dong, Minjun, Sun, Qi, Shi, Wentao, Zhao, Tongchao, Zhou, Zhihang, Huang, Yingying, Zhou, Xinyu, Zhu, Dongwang, Dou, Shengjin, Zhang, Zhiyuan, He, Yue, Zhang, Chenping, Xia, Ronghui, Zhu, Guopei, Zhong, Laiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389426/ https://www.ncbi.nlm.nih.gov/pubmed/36999830 http://dx.doi.org/10.1097/JS9.0000000000000353 |
Ejemplares similares
-
Neoadjuvant immunochemotherapy for locally advanced resectable oral squamous cell carcinoma: a prospective single-arm trial (Illuminate Trial)
por: Huang, Yingying, et al.
Publicado: (2023) -
Decreased Annexin A1 expression enhances sensitivity to docetaxel, cisplatin and 5‐fluorouracil combination induction chemotherapy in oral squamous cell carcinoma
por: Sun, Wenwen, et al.
Publicado: (2021) -
Diagnosis and management of hypoglossal nerve-derived schwannoma in the floor of mouth: a case series
por: Zhong, Jiayong, et al.
Publicado: (2022) -
Clinical retrospective analysis with a predictive model for diffused-tenosynovial giant cell tumors of the temporomandibular joint
por: Liu, Ying, et al.
Publicado: (2023) -
A feasibility and safety study of concurrent chemotherapy based on genetic testing in patients with high-risk salivary gland tumors: Preliminary results
por: Li, Rongrong, et al.
Publicado: (2018)